VIRACTA THERAPEUTICS INC's ticker is VIRX and the CUSIP is 92765F108. A total of 64 filers reported holding VIRACTA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,848 | -26.2% | 3,700 | 0.0% | 0.00% | -20.0% |
Q2 2023 | $5,217 | -11.3% | 3,700 | 0.0% | 0.01% | -37.5% |
Q1 2023 | $5,883 | +8.9% | 3,700 | 0.0% | 0.01% | +33.3% |
Q4 2022 | $5,402 | -66.2% | 3,700 | 0.0% | 0.01% | -14.3% |
Q3 2022 | $16,000 | -11.1% | 3,700 | 0.0% | 0.01% | 0.0% |
Q2 2022 | $18,000 | 0.0% | 3,700 | 0.0% | 0.01% | 0.0% |
Q1 2022 | $18,000 | -99.9% | 3,700 | 0.0% | 0.01% | -99.9% |
Q4 2021 | $13,505,000 | +44916.7% | 3,700 | 0.0% | 5.65% | +40278.6% |
Q3 2021 | $30,000 | -28.6% | 3,700 | 0.0% | 0.01% | -30.0% |
Q2 2021 | $42,000 | +23.5% | 3,700 | 0.0% | 0.02% | +53.8% |
Q1 2021 | $34,000 | – | 3,700 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 689,709 | $717,297 | 0.22% |
Aisling Capital Management LP | 288,571 | $300,114 | 0.12% |
BVF INC/IL | 3,614,662 | $3,759,248 | 0.10% |
TRUST CO OF TOLEDO NA /OH/ | 33,213 | $34,542 | 0.01% |
MAI Capital Management | 397,670 | $413,577 | 0.01% |
Laurion Capital Management LP | 698,000 | $725,920 | 0.00% |
RP Management, LLC | 3,700 | $3,848 | 0.00% |
UNITED BANK | 20,000 | $20,800 | 0.00% |
BOURGEON CAPITAL MANAGEMENT LLC | 7,500 | $7,800 | 0.00% |
XTX Topco Ltd | 12,084 | $12,567 | 0.00% |